Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 8:02 PM
Ignite Modification Date: 2025-12-24 @ 8:02 PM
NCT ID: NCT04643704
Eligibility Criteria: Inclusion Criteria: Any patient from 0 to 12 years of age, with FPIES or an IgE-mediated food allergy or celiac disease. Controls: chid from 0 to 12 years old, without any food avoidance for medical reason, and without chronical severe pathology Exclusion Criteria: General exclusion criteria: * Families and patients who do not understand French * Cured food allergy (FPIES, IgE or non IgE-mediated food allergy) * Allergic patient (FPIES, IgE-mediated food allergy) undergoing oral or epicutaneous tolerance induction Criteria for non-inclusion in the "FPIES" group: * Patient with mixed FPIES with associated IgE-mediated symptomatology * Non IgE-mediated food allergies other than FPIES Criteria for non-inclusion in the "celiac disease" group: \- Patient with hypersensitivity to non-celiac gluten Criteria for non-inclusion in the "control" group: * Current food avoidance, personal or in one of the household members due to allergy, or digestive disorders (abdominal pain, diarrhea for example) induced by the consumption of particular foods and requiring a strict avoidance diet * Chronic digestive pathology (chronic inflammatory bowel disease, functional bowel disorders with a correlation of symptoms with diet, esophagitis and eosinophilic enteropathy) * Chronic nutritional, metabolic or endocrine pathologies for which diet can have an impact: obesity, dyslipidemia, diabetes * Severe chronic respiratory pathology (eg: cystic fibrosis, chronic respiratory failure)
Healthy Volunteers: True
Sex: ALL
Maximum Age: 12 Years
Study: NCT04643704
Study Brief:
Protocol Section: NCT04643704